Teams at Lindus Therapeutics

Lead development strategy for a portfolio of in-licensed assets toward capital-efficient Phase 2 proof-of-concept readouts. Design Phase 1/2 studies, set target product profiles, drive regulatory and CMC plans, lead diligence and prioritize assets, build and manage a lean virtual development organization, and represent development strategy to investors, partners and the board.

Senior individual contributor responsible for statistical leadership across a portfolio of clinical-stage assets: due diligence for acquisitions, complex trial design (including adaptive/multi-cohort), high-stakes interim and final analyses, regulatory representation and submissions, and building statistical standards, templates and mentorship for the biostatistics function.

Lead regulatory strategy and agency interactions for an in‑licensed clinical-stage biopharma portfolio. Own pathway selection, endpoints, and filings (INDs, NDA/BLA involvement), manage external experts and KOLs, perform regulatory diligence, and advise executives to de-risk timelines and support exit readiness.